Drugs View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1971

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/40265

Recent publications latest 20 shown

  • 2022-11-23 Teprotumumab: A Review in Thyroid Eye Disease
  • 2022-11-23 Correction: Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
  • 2022-11-23 Spesolimab: First Approval
  • 2022-11-19 Deucravacitinib: First Approval
  • 2022-11-15 Valemetostat Tosilate: First Approval
  • 2022-11-14 Empagliflozin: A Review in Symptomatic Chronic Heart Failure
  • 2022-11-14 Correction to: Darinaparsin: First Approval
  • 2022-11-10 Teclistamab: First Approval
  • 2022-11-09 Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
  • 2022-11-04 Darinaparsin: First Approval
  • 2022-10-29 Pucotenlimab: First Approval
  • 2022-10-26 Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
  • 2022-10-25 Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy
  • 2022-10-17 Novel Drug Therapeutics in Celiac Disease: A Pipeline Review
  • 2022-10 Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
  • 2022-10 Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids
  • 2022-09-21 Cancer Pain Treatment Strategies in Patients with Cancer
  • 2022-09-21 The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis
  • 2022-09-19 Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
  • 2022-09-19 On the Verge of Precision Medicine in Diabetes
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "2.680000066757202", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "2.0799999237060547", 
            "type": "Rating"
          }
        ], 
        "description": "

    Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international clinicians and researchers to support clinical decision-making.   

    \n\n

    Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

    \n\n

    As a hybrid journal, Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

    \n\n

    Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

    \n", "editor": [ { "familyName": "Peters", "givenName": "Dene", "type": "Person" } ], "id": "sg:journal.1084788", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0012-6667", "1179-1950" ], "license": "Hybrid", "name": "Drugs", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "84788" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "71-612913" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "7600076" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "439975" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14747" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1084788" ], "sdDataset": "journals", "sdDatePublished": "2022-12-01T06:58", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1971", "type": "Periodical", "url": "https://link.springer.com/journal/40265" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1084788'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1084788'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1084788'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1084788'


     

    This table displays all metadata directly associated to this object as RDF triples.

    60 TRIPLES      20 PREDICATES      27 URIs      23 LITERALS      10 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1084788 schema:contentRating N58a02fe79bb642949c9d8a160d87e704
    2 Nf6ff1b1b05cd442ca694266162be85b6
    3 schema:description <p>Stay up to date with the latest developments in therapeutics by reading the world&rsquo;s most respected source of authoritative drug information. For 50 years <em>Drugs</em> has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international clinicians and researchers to support clinical decision-making.&nbsp;&nbsp;&nbsp;</p> <p>Through a rigorous and comprehensive program of peer-reviewed evaluations, <em>Drugs</em> provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.</p> <p>As a hybrid journal, <em>Drugs</em> does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice&trade; initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the &lsquo;How to publish with us, including Open Access&rsquo; link below.</p> <p><em>Drugs</em> offers a range of additional features designed to increase the visibility, readership and educational value of the journal&rsquo;s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager&reg;, supported by a database of international experts. This database is shared with other Adis journals.</p>
    4 schema:editor N013c18261bfe40bf97eaede1fb76e503
    5 schema:inLanguage en
    6 schema:isAccessibleForFree false
    7 schema:issn 0012-6667
    8 1179-1950
    9 schema:license Hybrid
    10 schema:name Drugs
    11 schema:productId N29706e32e5324c6f9327a0e2b75dcc60
    12 N7813485e849f45e7a9be40d64a0bcebe
    13 N83060fc790c14e4abccd10aff2bc3623
    14 N91eeac82a7294052b8f1681a59fcd96e
    15 N9f1221e0a33847a1ac87fd1ba264bd07
    16 schema:publisher Na4ddb938051a403aa06286dc59591223
    17 schema:publisherImprint Adis
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1084788
    19 schema:sdDatePublished 2022-12-01T06:58
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher N5c2db994040c4db886a9a762d4274e5b
    22 schema:startYear 1971
    23 schema:url https://link.springer.com/journal/40265
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset journals
    26 rdf:type schema:Periodical
    27 N013c18261bfe40bf97eaede1fb76e503 rdf:first N2cc3b681c1324ae6aeb077790e332b7a
    28 rdf:rest rdf:nil
    29 N1eac3ae41c064622a4b1f87b18e65d12 rdf:first sjr
    30 rdf:rest rdf:nil
    31 N26391e168e79421a850e5596338a1119 rdf:first snip
    32 rdf:rest rdf:nil
    33 N29706e32e5324c6f9327a0e2b75dcc60 schema:name lccn_id
    34 schema:value 71-612913
    35 rdf:type schema:PropertyValue
    36 N2cc3b681c1324ae6aeb077790e332b7a schema:familyName Peters
    37 schema:givenName Dene
    38 rdf:type schema:Person
    39 N58a02fe79bb642949c9d8a160d87e704 schema:author N1eac3ae41c064622a4b1f87b18e65d12
    40 schema:ratingValue 2.0799999237060547
    41 rdf:type schema:Rating
    42 N5c2db994040c4db886a9a762d4274e5b schema:name Springer Nature - SN SciGraph project
    43 rdf:type schema:Organization
    44 N7813485e849f45e7a9be40d64a0bcebe schema:name nsd_ids_id
    45 schema:value 439975
    46 rdf:type schema:PropertyValue
    47 N83060fc790c14e4abccd10aff2bc3623 schema:name nlm_unique_id
    48 schema:value 7600076
    49 rdf:type schema:PropertyValue
    50 N91eeac82a7294052b8f1681a59fcd96e schema:name era_ids_id
    51 schema:value 14747
    52 rdf:type schema:PropertyValue
    53 N9f1221e0a33847a1ac87fd1ba264bd07 schema:name dimensions_id
    54 schema:value 84788
    55 rdf:type schema:PropertyValue
    56 Na4ddb938051a403aa06286dc59591223 schema:name Springer International Publishing
    57 rdf:type schema:Organization
    58 Nf6ff1b1b05cd442ca694266162be85b6 schema:author N26391e168e79421a850e5596338a1119
    59 schema:ratingValue 2.680000066757202
    60 rdf:type schema:Rating
     




    Preview window. Press ESC to close (or click here)


    ...